Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yasmin for Infertility in Premature Ovarian Failure
NCT02757469Unknown
- Start
- May 2016
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of drospirenone in premature ovarian insufficiency (POI). Primary endpoint: Live Birth at 3 years. Status: unknown.
02
Drugs
drospirenone
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT02757469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02757469.